JS
Jagdeep Singh
About Jagdeep Singh
Data last updated:
Jagdeep Singh is a Managing Director at Psychocare Health Private Limited (since 2018), Director at Jips Pharmaceuticals Private Limited (since 2017) and Director at Kyracare Remedies Private Limited (since 2023), and holds 4 more current directorships. The companies operate in Pharma, Trading and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹68.58 Cr; the largest is Psychocare Health Private Limited at ₹40.92 Cr (FY 2024). Earlier, Jagdeep Singh was a Director at Future Generic Private Limited (2021–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Psychocare Health Private Limited U24304PB2018PTC048306 | Managing Director | 04 Sep 2018 | 2018 | ₹40.92 Cr (FY 2024) | Active |
 Jips Pharmaceuticals Private Limited U24304CH2017PTC041344 | Director | 13 Jan 2017 | 2017 | ₹27.63 Cr (FY 2023) | Active |
| Kyracare Remedies Private Limited U46497PB2023PTC057959 | Director | 18 Mar 2023 | 2023 | ₹1.7 Lakh (FY 2025) | Active |
| Sehatokart Ventures Private Limited U51909PB2022PTC056650 | Director | 11 Aug 2022 | 2022 | ₹1.3 Lakh (FY 2025) | Active |
| Rudrakyra Production Llp ACK-8679 | Designated Partner | 16 Dec 2024 | 2024 | Active | |
| Tas Derma Private Limited U21002PB2023PTC058144 | Director | 23 Mar 2023 | |||
| Mind In Peace Private Limited U21004PB2023PTC057981 | Director | 21 Mar 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Future Generic Private Limited U24290MH2021PTC357885 | Director | 25 Mar 2021 | 2021 | ₹31.5 Lakh (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jagdeep Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Supreet Singh | 07511639 | Psychocare Health Private Limited , Jips Pharmaceuticals Private Limited and 5 more | Director |
| Irvandeep Kaur | 07673286 | Jips Pharmaceuticals Private Limited | Director |
| Parvinder Jit Singh | 07673268 | Jips Pharmaceuticals Private Limited | Director |
| Devinder Kaur Gandhoke | 10849960 | Rudrakyra Production Llp | Designated Partner |
| Shuchi Singh | 10873401 | Rudrakyra Production Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jagdeep Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jagdeep Singh
Jagdeep Singh currently holds 7 directorships: Psychocare Health Private Limited (Managing Director, since 04 Sep 2018, revenue ₹40.92 Cr (FY 2024)); Jips Pharmaceuticals Private Limited (Director, since 13 Jan 2017, revenue ₹27.63 Cr (FY 2023)); Kyracare Remedies Private Limited (Director, since 18 Mar 2023, revenue ₹1.7 Lakh (FY 2025)); Sehatokart Ventures Private Limited (Director, since 11 Aug 2022, revenue ₹1.3 Lakh (FY 2025)); Rudrakyra Production Llp (Designated Partner, since 16 Dec 2024); and 2 more.
Jagdeep Singh was first appointed on 13 Jan 2017 as Director at Jips Pharmaceuticals Private Limited. The most recent appointment on record is 16 Dec 2024 at Rudrakyra Production Llp.
The 4 current companies of Jagdeep Singh that report revenue have a combined latest revenue of ₹68.58 Cr: Psychocare Health Private Limited ₹40.92 Cr (FY 2024); Jips Pharmaceuticals Private Limited ₹27.63 Cr (FY 2023); Kyracare Remedies Private Limited ₹1.7 Lakh (FY 2025); Sehatokart Ventures Private Limited ₹1.3 Lakh (FY 2025).
Jagdeep Singh held 1 earlier board appointment: Future Generic Private Limited (Director, 25 Mar 2021 to 03 May 2023).
The current boards of Jagdeep Singh's companies include Supreet Singh (Psychocare Health Private Limited), Irvandeep Kaur (Jips Pharmaceuticals Private Limited), Parvinder Jit Singh (Jips Pharmaceuticals Private Limited), Devinder Kaur Gandhoke (Rudrakyra Production Llp), Shuchi Singh (Rudrakyra Production Llp).